Retrospective Analysis of Survival Improvement by Molecular Biomarker-Based Personalized Chemotherapy for Recurrent Ovarian Cancer

Aggressive tumors such as epithelial ovarian cancer (EOC) are highly heterogeneous in their therapeutic response, making it difficult to improve overall response by using drugs in unselected patients. The goal of this study was to retrospectively, but independently, examine whether biomarker-based p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngchul, Guntupalli, Saketh R., Lee, Sun J., Behbakht, Kian, Theodorescu, Dan, Lee, Jae K., Diamond, Jennifer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914805/
https://www.ncbi.nlm.nih.gov/pubmed/24505259
http://dx.doi.org/10.1371/journal.pone.0086532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914805/
https://www.ncbi.nlm.nih.gov/pubmed/24505259
http://dx.doi.org/10.1371/journal.pone.0086532

Ejemplares similares